Literature DB >> 11876660

Quinolinate phosphoribosyltransferase: kinetic mechanism for a type II PRTase.

Hong Cao1, Beth L Pietrak, Charles Grubmeyer.   

Abstract

Quinolinate phosphoribosyltransferase (QAPRTase, EC 2.4.2.19) catalyzes the formation of nicotinate mononucleotide, carbon dioxide, and pyrophosphate from 5-phosphoribosyl 1-pyrophosphate (PRPP) and quinolinic acid (QA, pyridine 2,3-dicarboxylic acid). The enzyme is the only type II PRTase whose X-ray structure is known. Here we determined the kinetic mechanism of the enzyme from Salmonella typhimurium. Equilibrium binding studies show that PRPP and QA each form binary complexes with the enzyme, with K(D) values (53 and 21 microM, respectively) similar to their K(M) values (30 and 25 microM, respectively). Although neither PP(i) nor NAMN products bound well to the enzyme, 130-fold tighter binding of PP(i) (K(D) = 75 microM) and NAMN (K(D) = 6 microM) in a ternary complex was observed. Phthalic acid (K(D) = 21 microM) and PRPP each caused a 2.5-fold tightening of the other's binding. Isotope trapping experiments indicated that the E.QA complex is catalytically competent, whereas the E.PRPP complex could not be trapped. Pre-steady-state kinetics gave a linear rate of NAMN formation, indicating that on-enzyme phosphoribosyl transfer chemistry is rate-determining. Isotope trapping from the steady state revealed that nearly all QA and about one-third of PRPP in ternary enzyme.QA.PRPP complexes could be trapped as the product. Substrate inhibition by PRPP was observed. These data demonstrate a predominantly ordered kinetic mechanism in which productive binding of quinolinic acid precedes that of PRPP. An E.PRPP complex exists as a nonproductive side branch.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11876660     DOI: 10.1021/bi012148g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  The role of Phe181 in the hexamerization of Helicobacter pylori quinolinate phosphoribosyltransferase.

Authors:  M-K Kim; G B Kang; W K Song; S H Eom
Journal:  Protein J       Date:  2007-10       Impact factor: 2.371

Review 2.  NAD+ metabolism and oxidative stress: the golden nucleotide on a crown of thorns.

Authors:  Hassina Massudi; Ross Grant; Gilles J Guillemin; Nady Braidy
Journal:  Redox Rep       Date:  2012       Impact factor: 4.412

Review 3.  Glutaric aciduria type I and kynurenine pathway metabolites: a modified hypothesis.

Authors:  S Varadkar; R Surtees
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

4.  Substrate recognition by the hetero-octameric ATP phosphoribosyltransferase from Lactococcus lactis.

Authors:  Karen S Champagne; Elise Piscitelli; Christopher S Francklyn
Journal:  Biochemistry       Date:  2006-12-19       Impact factor: 3.162

5.  Purification, overproduction, and partial characterization of beta-RFAP synthase, a key enzyme in the methanopterin biosynthesis pathway.

Authors:  Joseph W Scott; Madeline E Rasche
Journal:  J Bacteriol       Date:  2002-08       Impact factor: 3.490

6.  Quinolinate salvage and insights for targeting NAD biosynthesis in group A streptococci.

Authors:  Leonardo Sorci; Ian K Blaby; Irina A Rodionova; Jessica De Ingeniis; Sergey Tkachenko; Valérie de Crécy-Lagard; Andrei L Osterman
Journal:  J Bacteriol       Date:  2012-11-30       Impact factor: 3.490

7.  Roles for cationic residues at the quinolinic acid binding site of quinolinate phosphoribosyltransferase.

Authors:  Zainab Bello; Charles Grubmeyer
Journal:  Biochemistry       Date:  2010-02-23       Impact factor: 3.162

8.  Interactions at the 2 and 5 positions of 5-phosphoribosyl pyrophosphate are essential in Salmonella typhimurium quinolinate phosphoribosyltransferase.

Authors:  Zainab Bello; Barbara Stitt; Charles Grubmeyer
Journal:  Biochemistry       Date:  2010-02-23       Impact factor: 3.162

9.  Biogenesis and Homeostasis of Nicotinamide Adenine Dinucleotide Cofactor.

Authors:  Andrei Osterman
Journal:  EcoSal Plus       Date:  2009-08

10.  Targeting NAD+ Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma Resistance.

Authors:  Esther P Jane; Daniel R Premkumar; Swetha Thambireddy; Brian Golbourn; Sameer Agnihotri; Kelsey C Bertrand; Stephen C Mack; Max I Myers; Ansuman Chattopadhyay; D Lansing Taylor; Mark E Schurdak; Andrew M Stern; Ian F Pollack
Journal:  Mol Cancer Res       Date:  2020-04-01       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.